microRNA:microRNASARS-CoV-2

Thalia Belmonte1, Manel Perez-Pons1, Iván D Benítez1

  • 1Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.

概括

这项研究确定了miR-106a-5p和miR-484作为可靠的内源控制物,用于在住院COVID-19患者中正常化微RNA (miRNA) 定量PCR数据,确保准确的生物标志物开发.